Business

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness

TORONTO, ON / ACCESSWIRE / November 28, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A)...

articleQuantum Biopharma Ltd. Subordinate Voting Shares Class BNovember 28, 20235/company/quantum-biopharma-ltd-ordinary-shares-class-b-sub-voting/news/update-provided-on-gbb-drink-lab-inc-litigation-and-safety-shot-previously-known-as-jupiter-wellness
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter Wellness

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot Previously known as Jupiter WellnessTORONTO, ON / ACCESSWIRE / November 28, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (\"FSD Pharma\" or the \"Company\"), is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The Company is providing this statement as an update regarding its litigation with GBB Drink Lab, Inc. (\"GBB\") previously referenced at: FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ:JUPW).In May 2023, GBB filed a lawsuit against FSD Pharma alleging a material breach of a mutual nondisclosure agreement and trade secret misappropriation. FSD Pharma has categorically denied these allegations and field a Motion to Dismiss the lawsuit, which is currently pending. See prior press release from August.In the few months since filing its lawsuit against FSD Pharma, GBB began operating under the name Jupiter Wellness (NASDAQ:JUPW) which acquired GBB\"s purported \"asset\" known as its Safety Shot product, which now trades under the name Safety Shot, Inc. (Nasdaq: SHOT). Regardless of the name it currently uses, GBB continues to try to use bully tactics in an effort to intimidate its competitors and critics through threats of litigation. Just as it has with FSD Pharma, SHOT has now issued additional press releases suggesting it intends to sue others, including its most recent public critic, Capybara Research, arising out of Capybara's most recently published research paper regarding Safety Shot.GBB's statements about its Safety Shot product, which SHOT claims will be released next month, have also been suspect. GBB has claimed that its product \"accelerates the process of converting alcohol to sugar in the body\" even though it is well-recognized and understood by the scientific community that at no point in the process of metabolizing alcohol is it converted into sugar. Similarly, shortly after Jupiter Wellness, Inc acquired GBB's assets, it claimed that GBB\"s Safety Shot product, \"lowers blood alcohol content by up to 50% in just thirty minutes,\" another extraordinary claim for which GBB provided no support. These suspect statements made by GBB and its affiliates should be carefully considered by anyone interested in alcohol det...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B